BIOCARE, INC. APPOINTS NEW CHIEF EXECUTIVE OFFICER & CHIEF OPERATING OFFICER TO EXECUTIVE LEADERSHIP TEAM [Yahoo! Finance]
Cencora, Inc. (COR)
Last cencora, inc. earnings: 4/30 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.coresite.com/investor-overview
Company Research
Source: Yahoo! Finance
April 29, 2024 /PRNewswire/ -- BioCare, a leading specialty pharmaceutical distribution partner comprised of BioCareSD and LogiCare3PL , today announced the appointment of James Frary as Chief Executive Officer (CEO) and Michael Kody as Chief Operating Officer (COO). Linda Matthews , who has served as BioCare's CEO for over 25 years, will be retiring at the end of the year and will continue to serve as an advisor to the organization. "James' tenure as BioCare's Chairman of the Board of Directors over the past two years has been invaluable to me and the company," said Linda Matthews . "His partnership and dedication have been instrumental in driving our success, and I am excited about the future for BioCare under his leadership." Mr. Frary brings over two decades of experience in the healthcare industry, most recently as CEO of US Acute Care Solutions, and before that, President of AmerisourceBergen Specialty Group. Mr. Frary joined the Board of Directors for BioCare as Chairman in
Show less
Read more
Impact Snapshot
Event Time:
COR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COR alerts
High impacting Cencora, Inc. news events
Weekly update
A roundup of the hottest topics
COR
News
- Cencora, Inc. (NYSE: COR) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Cencora, Inc. (NYSE: COR) had its price target raised by analysts at Robert W. Baird from $275.00 to $277.00. They now have an "outperform" rating on the stock.MarketBeat
- Pharma Wholesale and Distribution Market 10 Year Forecast Report 2024-2034: Global Market Set to Surpass the US$800 Billion Mark in 2024 [Yahoo! Finance]Yahoo! Finance
- Cencora Reports Fiscal 2024 Second Quarter ResultsBusiness Wire
- Cencora, Inc. (NYSE: COR) had its price target raised by analysts at Citigroup Inc. from $265.00 to $280.00. They now have a "buy" rating on the stock.MarketBeat
COR
Earnings
- 5/1/24 - Beat
COR
Sec Filings
- 5/10/24 - Form 4
- 5/7/24 - Form 144
- 5/3/24 - Form 8-K
- COR's page on the SEC website